Trials / Completed
CompletedNCT05503758
Biomechanical Properties of the Lumbar Paravertebral Muscles
Quantification of Different Lumbar Paravertebral Muscles Properties in Women Who Experienced Cesarean Delivery Under Different Types of Anaesthesia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 63 (actual)
- Sponsor
- South Valley University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- —
Summary
Cesarean delivery (CD) is an obstetric surgery for fetal delivery that involves both an abdominal incision (laparotomy) and a uterine incision (hysterotomy). It is presently the most prevalent surgery in the United States, with over 1 million women giving birth by cesarean section each year.
Detailed description
The anaesthetic types of choice for cesarean delivery are neuraxial and general anaesthesia. Neuraxial anesthesia is the gold standard anaesthesia for CD; it includes spinal and epidural anaesthesia. For spinal anaesthesia, local anesthetics are injected into the spinal canal, while for epidural anaesthesia, they are injected into the epidural space. Despite the superiority of neuraxial anaesthesia for cesarean delivery, general anesthesia is still performed to some extent especially when neuraxial anaesthesia is failed or inconsistent. General anesthesia involves a transient state of unconsciousness through the administration of inhaled anesthetic gases combined with intravenous drugs. LBP patients showed changes in their neuromuscular activity, reduction in the lumbar muscle flexibility, and alteration of the biomechanical properties of the lumbar muscles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia) | The MyotoPRO device is a portable objective device for measuring the contractile (tone), and biomechanical (stiffness) properties of lumbar paravertebral muscles (LPVMs). |
Timeline
- Start date
- 2021-06-28
- Primary completion
- 2022-01-29
- Completion
- 2022-01-29
- First posted
- 2022-08-17
- Last updated
- 2025-10-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05503758. Inclusion in this directory is not an endorsement.